Walter Strapps

Former employees at AstraZeneca and Merck/Intellia, Shawn Davis and Walter Strapps share how they're using automation and machine learning to overcome challenges and limitations in RNA delivery for genetic medicine. They discuss the importance of safe and predictable delivery, extra hepatic delivery, testing lipid nanoparticles, tracking cargo, the company's business model and potential pipeline, and the significance of speed in the market for early patient access.